Profile
BSGM ABT BSX-PA BSX SYK MDT
Company Name BioSig Technologies, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $140.72M $222.72B $175.45B $157.52B $149.38B $118.44B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Anthony Amato Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
BSGM ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 1 1 3 3
Quant Rating Sell Strong Sell Strong Sell Neutral Neutral
Trading
BSGM ABT BSX-PA BSX SYK MDT
Last Close $4.44 $128.01 $122.18 $106.47 $400.57 $92.44
High 52 $11.46 $140.22 $122.18 $107.76 $403.53 $94.5
Low 52 $0.25 $105.32 $122.18 $72.96 $315.94 $79.61
Price vs. 52 Week High -61.26 % -8.71 % 0 % -1.2 % -0.73 % -2.18 %
Price vs. 52 Week Low 1676 % 21.54 % 0 % 45.93 % 26.79 % 16.12 %
Total Return
BSGM ABT BSX-PA BSX SYK MDT
1 Month Return -38.08 % -5.88 % 0 % -0.88 % 1.25 % 6.05 %
3 Month Return 335.08 % -2.1 % 0 % 3.5 % 6.89 % 9.06 %
6 Month Return 439.36 % -0.62 % 0 % 3.33 % 2.6 % 0.49 %
9 Month Return 300 % 11.85 % 0 % 26.77 % 10.22 % 2.14 %
YTD Return 197.99 % 13.17 % 0 % 19.2 % 11.25 % 15.72 %
1 Year Return 959.67 % 21.54 % 0 % 43.82 % 21.3 % 14.39 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BSGM ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.81 % - - 0.85 % 3.04 %
Dividend Paid and Capex Coverage Ration (TTM) -651.29 % 1.44 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) -0.07 % 27.93 % 0.92 % 0.92 % 43.2 % 76.97 %
Growth
BSGM ABT BSX-PA BSX SYK MDT
Asset Growth -53.17 % 11.2 % 12.12 % 1.89 %
Gross Profit Growth 122.22 % 5.01 % 16.12 % 3.88 %
Revenue Growth 122.22 % 4.59 % 17.61 % 3.62 %
Revenue 3 Year -97.84 % -0.18 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 41.05 %
EBIT Growth 55.78 % 3.71 % 14.98 % -100 %
Net Income Growth 64.43 % 134.18 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 92.14 % 94.27 % 72.14 % -3.39 %
Net Income 5 Yeari Growth Per Share 95.51 % 271.11 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 96.65 % 410.99 % 524.92 % 48.51 %
Operating Income Growth 54.89 % 5.36 % 11.1 % 15.77 %
Operating Cash Flow Growth (CFG) 72.52 % 17.86 % 37.24 % 3.79 %
Operating 3 Year CFG 95.7 % -16.72 % 77.55 % 0.13 %
Operating 5 Year CFG 95.47 % 42.4 % 76.92 % 1.55 %
Operating 10 Year CFG 93.45 % 102.79 % 143.61 % 22.45 %
EPS Growth 81.6 % 134.55 % 16.67 % 31.05 %
EPS Diluted Growth 81.6 % 133.64 % 16.82 % 30.8 %
Book Value Per Share 74.21 % 23.54 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -102.75 % 36.46 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -101.84 % 56.53 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 95.52 % 92.83 % 186.31 % -23.12 %
Dividend Per Share Growth -47.64 % 8.02 % -100 % 1.11 %
Dividend 3 Year Growth Per Share -76.13 % 22.8 % -100 % 10.78 %
Dividend 5 Year Growth Per Share -99.67 % 72.53 % - 29.33 %
Dividend 10 Year Growth Per Share -99.98 % 148.92 % - 128.74 %
Debt Growth -77.43 % -5.37 % 17.44 % 9.48 %
Free Cash Flow Growth 72.81 % 25.54 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
BSGM ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -730.77 % 56.14 % 68.27 % 68.27 % 63.57 % 64.06 %
Return on Assets TTM -220.53 % 17.16 % 6.24 % 6.24 % 6.21 % 5.09 %
Return on Equity TTM -3530.07 % 31.84 % 11.78 % 11.78 % 10.73 % 9.62 %
Return on Capital Employed TTM -453.05 % 11.05 % 8.97 % 8.97 % 9.61 % 7.56 %
Net Income Per EBT TTM 100.2 % 176.99 % 83.5 % 83.5 % 85.78 % 82.85 %
EBT Per Ebit TTM 78.36 % 104.44 % 95.3 % 95.3 % 91.04 % 94.51 %
EBIT Per Revenue TTM -47726.92 % 17.54 % 17.02 % 17.02 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -7598.33 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 0.24 4.46 6.87 6.87 5.86 5.15
Payables Turnover TTM - 4.49 5.85 5.85 - 4.74
Inventory Turnover TTM - 2.85 2.05 2.05 1.66 2.12
Fixed Asset Turnover TTM 21.14 % 394.34 % 481.99 % 481.99 % 656.62 % 490.52 %
Asset Turnover TTM 0.59 % 52.93 % 46.07 % 46.07 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -0.22 5.15 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -0.22 3.83 1.94 1.94 9.37 4.04
Cash Per Share TTM 17.93 % 393.83 % 49.04 % 49.04 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -17534.62 % 20.76 % 20.61 % 20.61 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -7598.33 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -30.87 33.46 54.83 54.83 41.76 22.84
Price To Operating Cash Flows Ratio TTM -20.84 24.86 41.29 41.29 34.79 16.83
Price Cash Flow Ratio TTM -20.84 24.86 41.29 41.29 34.79 16.83
Income Statement (TTM)
BSGM ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 100% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.01B $10.83B $3.86B $3.86B $5.72B $5.96B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -0.07 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
BSGM ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.19B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $-0B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
BSGM ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $-0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.575
ADGM Adagio Medical Holdings, Inc. 1.37
AEMD Aethlon Medical, Inc. 1.21
AFIB Acutus Medical, Inc. 0.0005
AHCO AdaptHealth Corp. 9.12
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 203.55
ALUR Allurion Technologies Inc. 2.73
AMIX Autonomix Medical, Inc. Common Stock 1.33
ANIK Anika Therapeutics, Inc. 8.08
AORT Artivion, Inc. 31.59
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.92
ARAY Accuray Incorporated 1.345
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.725
AVNS Avanos Medical, Inc. 11.68
AVR Anteris Technologies Global Corp. Common Stock 3.33
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to BSGM
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00026 312.27
VXF Vanguard Extended Market Index Fund 0.00172 198.774
IWC iShares Micro-Cap ETF 0.00047 131.515
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00019 106.29
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 106.28
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.18 72.5283
VTSAX Vanguard Total Stock Market Index Fund 0 152.14
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00172 151.04
VITSX Vanguard Total Stock Market Index Fund 0 152.17
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000092142 107.64
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00172 151.06
VEMPX Vanguard Extended Market Index InstlPlus 0.00172 372.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00026 285.44
Unlock